Following its participation in a six-month PlayBeyondBio acceleration program in Israel, docdok.health AG won a strategic partnership with the corona vaccine developer AstraZeneca. The two will collaborate on three projects to jointly develop digital disease management solutions based on the docdok platform.
The PlayBeyondBio Acceleration program, established by Jerusalem Venture Partners (JVP), the pharmaceutical giant AstraZeneca and Margalit Startup City Community, provides digital health startups with a platform to meet and work with world’s leading ecosystem players to revolutionise digital health worldwide.
Nine startups participated in the six-month program to define their vision, identify potential markets, and develop marketing strategies and technological integration. Upon graduation, two startups including docdok.health AG won international pilots and new collaborations with AstraZeneca.
docdok.health is a Swiss (-Israeli) startup specialising in personalised healthcare solutions that foster value-based healthcare. Its cloud-based platform docdok allows for synchronous and asynchronous communication between healthcare providers and patients. Also referred to as ‘Netflix of healthcare’, Docdok helps monitor symptoms when a patient is not under direct medical supervision. The startup develops disease-specific apps, which monitor symptoms, alerts any deterioration, and monitors drug treatment.
The startup and AstraZeneca will collaborate on three projects in three countries, leveraging docdok’s technology platform and the parties’ combined expertise, capabilities and network in the area of respiratory diseases.
(RAN)
Please login or sign up to comment.
Commenting guidelines